The 73 rating InvestorsObserver gives to Cara Therapeutics Inc (CARA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 90 percent of stocks in the Biotechnology industry, CARA’s 73 overall rating means the stock scores better than 73 percent of all stocks.
CARA has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on CARA!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Cara Therapeutics Inc Stock Today?
Cara Therapeutics Inc (CARA) stock has risen 5.77% while the S&P 500 is down -0.04% as of 3:12 PM on Friday, Dec 2. CARA is up $0.69 from the previous closing price of $11.96 on volume of 220,524 shares. Over the past year the S&P 500 is lower by -10.97% while CARA is down -1.86%. CARA lost -$1.66 per share the over the last 12 months.
Click Here to get the full Stock Report for Cara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
